J7311 |
 |
Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
short | Inj., retisert, 0.01 mg |
RVU | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 59.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 59.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
J7312 |
 |
Injection, dexamethasone, intravitreal implant, 0.1 mg
short | Dexamethasone intra implant |
RVU | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 14.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 14.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
J7313 |
 |
Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
short | Inj., iluvien, 0.01 mg |
RVU | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 38.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 38.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
J7314 |
 |
Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg
short | Inj., yutiq, 0.01 mg |
RVU | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
|
|
J7315 |
 |
Mitomycin, ophthalmic, 0.2 mg
short | Ophthalmic mitomycin |
RVU | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 2.0 | 3 Date of Service Edit: Clinical | Prescribing Information | OPH | 2.0 | 3 Date of Service Edit: Clinical | Prescribing Information |
|
|
|
J7316 |
 |
Injection, ocriplasmin, 0.125 mg
short | Inj, ocriplasmin, 0.125 mg |
RVU | CPT Modifier | Physician Component | Facility Practice | Nonfacility Practice | Professional Liability Insurance | Total Facility | Total Nonfacility | Global Period |
---|
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | XXX |
|
MUE | Location | Value | Ajudication Indicator | Rationale |
---|
PRA | 3.0 | 2 Date of Service Edit: Policy | Anatomic Consideration | OPH | 3.0 | 2 Date of Service Edit: Policy | Anatomic Consideration |
|
|
|